Literature DB >> 30328562

Expanding the Scope of Costs and Benefits for Economic Evaluations in Health: Some Words of Caution.

Christopher McCabe1.   

Abstract

Mesh：

Year:  2019        PMID： 30328562     DOI： 10.1007/s40273-018-0729-z

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  19 in total

1.  Too important to ignore: informal caregivers and other significant others.

Authors:  Werner B F Brouwer
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

Review 2.  Unrelated medical costs in life-years gained: should they be included in economic evaluations of healthcare interventions?

Authors:  David R Rappange; Pieter H M van Baal; N Job A van Exel; Talitha L Feenstra; Frans F H Rutten; Werner B F Brouwer
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

3.  Productivity costs in cost-effectiveness analysis: numerator or denominator: a further discussion.

Authors:  W B Brouwer; M A Koopmanschap; F F Rutten
Journal:  Health Econ       Date:  1997 Sep-Oct       Impact factor: 3.046

4.  Caring for and caring about: disentangling the caregiver effect and the family effect.

Authors:  Ana Bobinac; N Job A van Exel; Frans F H Rutten; Werner B F Brouwer
Journal:  J Health Econ       Date:  2010-06-01       Impact factor: 3.883

5.  Estimating the Reference Incremental Cost-Effectiveness Ratio for the Australian Health System.

Authors:  Laura Catherine Edney; Hossein Haji Ali Afzali; Terence Chai Cheng; Jonathan Karnon
Journal:  Pharmacoeconomics       Date:  2018-02       Impact factor: 4.981

6.  Incorporating carer effects into economic evaluation.

Authors:  Simon Dixon; Mel Walker; Sam Salek
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

7.  Variation in the spillover effects of illness on parents, spouses, and children of the chronically ill.

Authors:  Tara A Lavelle; Eve Wittenberg; Kara Lamarand; Lisa A Prosser
Journal:  Appl Health Econ Health Policy       Date:  2014-04       Impact factor: 2.561

Review 8.  Disutility of illness for caregivers and families: a systematic review of the literature.

Authors:  Eve Wittenberg; Lisa A Prosser
Journal:  Pharmacoeconomics       Date:  2013-06       Impact factor: 4.981

9.  Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine.

Authors:  Gillian D Sanders; Peter J Neumann; Anirban Basu; Dan W Brock; David Feeny; Murray Krahn; Karen M Kuntz; David O Meltzer; Douglas K Owens; Lisa A Prosser; Joshua A Salomon; Mark J Sculpher; Thomas A Trikalinos; Louise B Russell; Joanna E Siegel; Theodore G Ganiats
Journal:  JAMA       Date:  2016-09-13       Impact factor: 56.272

10.  A Framework for Including Family Health Spillovers in Economic Evaluation.

Authors:  Hareth Al-Janabi; Job van Exel; Werner Brouwer; Joanna Coast
Journal:  Med Decis Making       Date:  2015-09-16       Impact factor: 2.583
View more
  8 in total

1.  Spillover Effects on Caregivers' and Family Members' Utility: A Systematic Review of the Literature.

Authors:  Eve Wittenberg; Lyndon P James; Lisa A Prosser
Journal:  Pharmacoeconomics       Date:  2019-04       Impact factor: 4.981

2.  Advances in Methods and Novel Applications for Measuring Family Spillover Effects of Illness.

Authors:  Lisa A Prosser; Eve Wittenberg
Journal:  Pharmacoeconomics       Date:  2019-04       Impact factor: 4.981

3.  The Inclusion of Spillover Effects in Economic Evaluations: Not an Optional Extra.

Authors:  Werner B F Brouwer
Journal:  Pharmacoeconomics       Date:  2019-04       Impact factor: 4.981

4.  The Inclusion of Spillover Effects in Economic Evaluation: A Public Health Economics Perspective.

Authors:  Rhiannon Tudor Edwards
Journal:  Pharmacoeconomics       Date:  2019-04       Impact factor: 4.981

5.  Future Offspring Costs in Economic Evaluation.

Authors:  Evelyn Verbeke; Jeroen Luyten
Journal:  Pharmacoeconomics       Date:  2021-10-29       Impact factor: 4.981

6.  Family Spillover Effects: Are Economic Evaluations Misrepresenting the Value of Healthcare Interventions to Society?

Authors:  Ashley A Leech; Pei-Jung Lin; Brittany D'Cruz; Susan K Parsons; Tara A Lavelle
Journal:  Appl Health Econ Health Policy       Date:  2022-08-23       Impact factor: 3.686

7.  Provider and household costs of Plasmodium vivax malaria episodes: a multicountry comparative analysis of primary trial data.

Authors:  Angela Devine; Ayodhia P Pasaribu; Tedlla Teferi; Huong-Thu Pham; Ghulam Rahim Awab; Febrina Contantia; Thuy-Nhien Nguyen; Viet-Thanh Ngo; Tinh-Hien Tran; Asrat Hailu; Kim Gilchrist; Justin A Green; Gavin Ckw Koh; Kamala Thriemer; Walter Rj Taylor; Nicholas Pj Day; Ric N Price; Yoel Lubell
Journal:  Bull World Health Organ       Date:  2019-09-27       Impact factor: 9.408

Review 8.  Carers' Health-Related Quality of Life in Global Health Technology Assessment: Guidance, Case Studies and Recommendations.

Authors:  Becky Pennington; Jack Eaton; Anthony J Hatswell; Helen Taylor
Journal:  Pharmacoeconomics       Date:  2022-07-12       Impact factor: 4.558
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.